Results 21 to 30 of about 1,917,601 (292)

Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use

open access: yesTherapeutics and Clinical Risk Management, 2018
Diego Jose Maselli,1 Linda Rogers,2 Jay I Peters1 1Division of Pulmonary Diseases and Critical Care, University of Texas Health, San Antonio, TX, USA; 2Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Mount Sinai &ndash ...
Maselli DJ, Rogers L, Peters JI
doaj   +1 more source

Response to benralizumab in patients with severe eosinophilic asthma. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Abstract Background: Severe asthma represents a significant public health challenge, and monoclonal antibodies such as benralizumab represent an effective therapeutic option for achieving disease control. Objective: To evaluate the effectiveness of benralizumab in patients with severe eosinophilic asthma by assessing changes in fractional exhaled ...
Velasco-Santos JI   +3 more
europepmc   +3 more sources

Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study

open access: yesBMC Pulmonary Medicine, 2022
Background Eosinophilia is a significant factor in asthma severity; however, the prevalence of severe eosinophilic asthma in Saudi Arabia is largely unknown.
Hamdan Al-Jahdali   +6 more
doaj   +1 more source

Severe asthma: adding new evidence – Latin American Thoracic Society

open access: yesERJ Open Research, 2021
This document constitutes a summary of the clinical practice guidelines (CPGs) prepared at the initiative of the Latin American Thoracic Society (ALAT). Due to new evidence in the treatment of severe asthma, it was agreed to select six clinical questions,
Gabriel García   +22 more
doaj   +1 more source

Successful treatment with dupilumab for mucus plugs in severe asthma

open access: yesRespirology Case Reports, 2023
A 29‐year‐old man presented to our hospital with severe eosinophilic asthma. He needed a short OCS burst for exacerbation of asthma once every 1 or 2 months, although he used a high dose of inhaled corticosteroids and a long‐acting beta‐2 agonists. Chest
Moriyasu Anai   +7 more
doaj   +1 more source

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy

open access: yesPharmaceutics, 2023
The role of type 2 inflammation has been progressively associated with many diseases, including severe asthma, atopic dermatitis, nasal polyposis, eosinophilic granulomatosis with polyangiitis, and, recently, eosinophilic esophagitis.
Diego Bagnasco   +7 more
doaj   +1 more source

Targeting eosinophils: severe asthma and beyond [PDF]

open access: yesDrugs in Context, 2019
Recent research in the field of bronchial asthma has mainly focused on eosinophilic disease phenotype. Several trials proved the efficacy and safety profile of eosinophils and interleukin (IL)-5 targeting molecules, currently approved for severe asthma and available on the market.
Caminati, Marco   +3 more
openaire   +5 more sources

Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma.

open access: yesPLoS ONE, 2021
PurposeTo characterize the clinical phenotypes of severe eosinophilic asthma based on early responsiveness to benralizumab in terms of forced expiratory volume in 1 second (FEV1) improvement.Patients and methodsSixty-four participants diagnosed with ...
Hideyasu Yamada   +10 more
doaj   +1 more source

Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort [PDF]

open access: yes, 2021
BACKGROUND: Phenotypic characteristics of eosinophilic and non-eosinophilic asthma patients are not well-characterized in global, real life severe asthma cohorts.RESEARCH QUESTION: What is the prevalence of eosinophilic and non-eosinophilic phenotypes in
Taube, Christian   +343 more
core   +1 more source

Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma

open access: yesAllergology International, 2017
Type-2/eosinophilic inflammation plays a pivotal role in asthma. The identification of severe type-2/eosinophilic asthma is important for improving the management of patients with asthma.
Tadao Nagasaki   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy